ArticleAMB Express2026
Nano-chitosan modified restorative materials suppress Streptococcus mutans biofilm and virulence gene expression.
Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary caries and biofilm production remain a persistent concern, prompting the development of antibacterial restorative materials. However, worries about synthetic additives’ safety and long-term effects urge the use of natural, biocompatible alternatives. This study explored the antibacterial efficacy of chitosan (CH) and nano-chitosan (NCH) incorporated into different restorative materials: amalgam (Am), glass ionomer cement (G), and resin composite (R). This study employs a direct comparative analysis of both modified and unmodified restorative materials against Am to evaluate their efficacy against Streptococcus mutans ATCC 25,175 using agar diffusion, broth inhibition, biofilm formation assays, and qPCR investigation of virulence genes (ldh and gtfB). Incorporating CH and NCH, especially at 15%, decreased biofilm biomass, downregulated virulence gene expression, and significantly increased the effectiveness of bacterial growth suppression. When compared to controls, the G modified with 15% NCH (GN15) showed the strongest inhibition of bacterial growth by 43.1%. The most significant finding was the ability of GN15 to downregulate the expression of ldh and gtfB by 50% and 28%, respectively, indicating a disruption in acid production and biofilm matrix synthesis. While Am showed the highest overall inhibition (86%, 65%). These results demonstrate that nano-chitosan is a biocompatible and promising addition to restorative materials, providing improved defense against cariogenic biofilms and facilitating the creation of dental biomaterials of the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.